Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review

Area of Science:

• Immunology
• Vaccinology
• Autoimmune Diseases

Background:

• Autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS), and type 1 diabetes (T1D), are driven by aberrant T cell-mediated autoimmune responses.
• Current vaccines primarily target infectious diseases, are preventative, and elicit antibody responses in naive individuals.

Purpose of the Study:

• To review the challenges and progress in developing therapeutic vaccines for autoimmune diseases.
• To compare the immunological considerations for infectious disease vaccines versus autoimmune disease vaccines.
• To detail the rationale for a therapeutic vaccine for RA, with brief mentions of T1D and MS.

Main Methods:

• Comparative analysis of immune responses in infectious and autoimmune diseases.
• Review of vaccine development approaches, including formulations, animal models, and success indicators.
• Focus on therapeutic strategies rather than preventative measures.

Main Results:

• Autoimmune disease vaccines must be therapeutic, aiming to resolve existing autoimmune conditions.
• Key considerations include disease triggers, autoantigens, and the nature of pathogenic versus protective immune responses.
• Progress has been made, but significant hurdles remain in translating research into effective treatments.

Conclusions:

• Therapeutic vaccines for autoimmune diseases present distinct challenges compared to infectious disease vaccines.
• Understanding autoantigens and modulating the immune response are critical for vaccine development.
• Further research and innovative approaches are needed to advance vaccine strategies for conditions like RA, MS, and T1D.